Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06349642
Status:
RECRUITING
Last Update Posted:
2024-05-10
First Post:
2024-04-01
Brief Title:
Predicting Response to Immune Checkpoint Inhibitors Across Solid Tumors Using a Live Tumor Diagnostic Platform
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ELEPHAS-04
Brief Summary:
This study is being done to collect tissue samples to test how accurately a tumor response platform Elephas can predict clinical response across multiple types of immunotherapies chemoimmunotherapy and tumor types
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2024-02979 | REGISTRY | CTRP Clinical Trials Reporting Program | None |
| 23-008413 | OTHER | None | None |